Macular Edema
4 competing products in clinical development for Macular Edema.
Pipeline by Phase
Phase 21
Phase 33
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Faricimab + Aflibercept | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| Faricimab + Aflibercept | Chugai Pharmaceutical | Phase 3 | Completed | 40 |
| 4 mg CLS-TA + Sham + IVT aflibercept | Clearside Biomedical | Phase 2 | Completed | 25 |
| suprachoroidal CLS-TA + suprachoroidal sham + Lucentis or Avastin | Clearside Biomedical | Phase 3 | Terminated | 22 |